Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




White Blood Cells "Remember” Prior Infections

By Biotechdaily staff writers
Posted on 23 May 2002
A group of white blood cells, the gamma delta T cells, have been found to demonstrate "memory” characteristics that enable them to launch a sustained immune response against tuberculosis bacteria. More...
This finding, reported in the March 22, 2002, issue of the journal Science, contributes important new insights as to how the immune system combats infection, a part of the continuing effort to develop a more effective tuberculosis vaccine.

The immune system relies on two separate types of immune responses: innate immunity and acquired immunity. T cells with innate immunity, including the gamma delta T cells, function as the immune system's "first line of defense” against foreign microbes, kicking in within hours of infection. T cells that are part of the acquired immune response then take center stage, playing a crucial role in eliminating foreign pathogens once an infection has developed. Acquired immunity takes time to mature, anywhere from days to weeks. It is the more effective of the two immune responses because it not only recognizes and attacks specific protein sequences of the foreign intruder, it also ‘remembers' them.

After an initial infection has been contained, these T cells switch roles and become ‘memory cells,' according to co-author Dr. Norman L. Letvin, of Beth Israel Deaconess Medical Center (Boston, MA, USA). "They then quietly ‘hang out' in the background until another infection develops, and then these memory cells respond very quickly and forcefully to ward off the new infection.”

Although evidence had existed that the gamma delta T cells provided protection against a range of infections, the immune responses of these cells had not been analyzed in detail. In the new study, lead author Dr. Zheng Chen and colleagues used macaque monkeys to study them. They injected macaques with BCG, bacteria closely related to the tuberculosis bacteria, and then evaluated their T cell memory response when the animals were challenged with a fresh injection. As early as four to six days after the second BCG inoculation, there was a marked expansion of the gamma delta T cells in the blood of the monkeys, which was two to nine times as great as the expansion during the primary infection. Furthermore, the authors found that the expansion of the cells lasted as long as seven months after the second inoculation.

"This study, for the first time, shows that this population of gamma delta T cells straddles the boundaries between innate and more mature immunity, suggesting that innate and acquired immunity cannot always be easily differentiated, said Dr. Letvin. "Not only do these T cells have memory capabilities, but the monkeys are calling upon them to fight infection.”


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Automatic Western Blot Analyzer
Tenfly Phoenix Blot Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.